Agency Forms Undergoing Paperwork Reduction Act Review, 9777-9778 [2020-03343]
Download as PDF
<![CDATA[
lotter on DSKBCFDHB2PROD with NOTICES
Federal Register / Vol. 85, No. 34 / Thursday, February 20, 2020 / Notices
If you file your comment on paper,
write ‘‘Risk-Based Pricing Rule, PRA
Comment, P145403’’ on your comment
and on the envelope, and mail your
comment to the following address:
Federal Trade Commission, Office of the
Secretary, 600 Pennsylvania Avenue
NW, Suite CC–5610 (Annex J),
Washington, DC 20580, or deliver your
comment to the following address:
Federal Trade Commission, Office of the
Secretary, Constitution Center, 400 7th
Street SW, 5th Floor, Suite 5610,
Washington, DC 20024. If possible,
please submit your paper comment to
the Commission by courier or overnight
service.
Because your comment will be placed
on the public record, you are solely
responsible for making sure that your
comment does not include any sensitive
or confidential information. In
particular, your comment should not
include any sensitive personal
information, such as your or anyone
else’s Social Security number; date of
birth; driver’s license number or other
state identification number, or foreign
country equivalent; passport number;
financial account number; or credit or
debit card number. You are also solely
responsible for making sure that your
comment does not include any sensitive
health information, such as medical
records or other individually
identifiable health information. In
addition, your comment should not
include any ‘‘trade secret or any
commercial or financial information
which . . . is privileged or
confidential’’—as provided by Section
6(f) of the FTC Act, 15 U.S.C. 46(f), and
FTC Rule 4.10(a)(2), 16 CFR 4.10(a)(2)—
including in particular competitively
sensitive information such as costs,
sales statistics, inventories, formulas,
patterns, devices, manufacturing
processes, or customer names.
Comments containing material for
which confidential treatment is
requested must be filed in paper form,
must be clearly labeled ‘‘Confidential,’’
and must comply with FTC Rule 4.9(c).
In particular, the written request for
confidential treatment that accompanies
the comment must include the factual
and legal basis for the request, and must
identify the specific portions of the
comment to be withheld from the public
record. See FTC Rule 4.9(c). Your
comment will be kept confidential only
if the General Counsel grants your
request in accordance with the law and
the public interest. Once your comment
has been posted on the public FTC
website—as legally required by FTC
Rule 4.9(b)—we cannot redact or
remove your comment from the FTC
website, unless you submit a
VerDate Sep<11>2014
19:48 Feb 19, 2020
Jkt 250001
confidentiality request that meets the
requirements for such treatment under
FTC Rule 4.9(c), and the General
Counsel grants that request.
The FTC Act and other laws that the
Commission administers permit the
collection of public comments to
consider and use in this proceeding as
appropriate. The Commission will
consider all timely and responsive
public comments that it receives on or
before April 20, 2020. For information
on the Commission’s privacy policy,
including routine uses permitted by the
Privacy Act, see https://www.ftc.gov/
site-information/privacy-policy.
Heather Hippsley,
Deputy General Counsel.
[FR Doc. 2020–03371 Filed 2–19–20; 8:45 am]
BILLING CODE 6750–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–20–19BPL]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Aerosols from
cyanobacterial blooms: Exposures and
health effects in a highly exposed
population, to the Office of Management
and Budget (OMB) for review and
approval. CDC previously published a
‘‘Proposed Data Collection Submitted
for Public Comment and
Recommendations’’ notice on
September 19, 2019 to obtain comments
from the public and affected agencies.
CDC received 162 comments related to
the previous notice. This notice serves
to allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
9777
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Proposed Project
Aerosols from cyanobacterial blooms:
Exposures and health effects in a highly
exposed population—New—National
Center for Environmental Health
(NCEH), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Algal toxins from cyanobacterial
harmful algal blooms (CyanoHABs)
include some of the most potent natural
chemicals. People and animals are at
risk for exposure to toxins produced by
CyanoHABs in recreational waters,
drinking water sources, or in improperly
treated water used for medical purposes
such as renal dialysis. Additional
potential exposure sources include
contaminated dietary supplements or
fish harvested from lakes with ongoing
CyanoHABs.
Although outbreaks of human illness
associated with CyanoHABs were
sporadically recorded for decades,
information about clinical signs and
symptoms from cyanobacterial toxin
poisonings is primarily from animal
poisonings and laboratory studies. The
primary effects include acute
hepatotoxicity, acute neurotoxicity,
gastrointestinal symptoms, and
respiratory, dermatologic, and allergic
reactions.
A significant source of cyanobacterial
toxin exposure is recreational use of
contaminated fresh water bodies
because large populations are likely to
be exposed and toxins may occur in
high concentrations. In the United
States, the U.S. Environmental
E:\FR\FM\20FEN1.SGM
20FEN1
9778
Federal Register / Vol. 85, No. 34 / Thursday, February 20, 2020 / Notices
Protection Agency (EPA) provided
guidance, but not regulations, on
acceptable levels of the cyanobacterial
toxins, microcystins and
cylindrospermopsin, in drinking and
recreational waters. Data from
epidemiologic studies designed to
evaluate the associations among
environmental cyanobacteria toxin
concentrations, human biomarkers of
cyanobacteria toxin exposure, and
health symptoms are needed to develop
more specific exposure guidelines.
In addition to cyanobacterial toxins,
other chemicals produced by
cyanobacteria, such as geosmin and
methylisoborneal (MIB), may be present
in aerosols generated during a
CyanoHAB. Geosmin and MIB produce
a musty odor and taste in water that is
noticeable at very low concentrations.
CyanoHABs may present additional
health risks as they die off and release
hydrogen sulfide and methane into the
air.
The National Center for
Environmental Health (NCEH), Centers
for Disease Control and Prevention
(CDC), requests a three-year Paperwork
Reduction Act (PRA) clearance for a
new information collection request
titled ‘‘Aerosols from cyanobacterial
blooms: exposures and health effects.’’
NCEH is authorized to conduct research
under the Public Health Service Act,
Section 301, ‘‘Research and
investigation,’’ (42 U.S.C. 241). We will
conduct a cohort study of 200 people
highly exposed to CyanoHABs in
Florida. We define ‘‘highly exposed’’ as
those exposed because of their
occupation (e.g., lock gate keepers,
fishing guides) and those exposed
because they live on a canal or river and
spend at least two hours outside on
most days.
Bloom composition and
concentrations of toxins can vary over
time during a bloom and CDC is
interested in not only exposure, but also
how exposure varies as the blooms
develop, mature, and die off. We cannot
predict when or where a bloom may
occur. Thus, we will work closely with
the Florida Department of
Environmental Protection to identify
when a bloom develops. Once a bloom
is verified, we will initiate the study
(i.e., recruit and enroll participants) in
the area affected by the bloom. We will
collect data on five study days for each
participant during the bloom season
(approximately March–November). The
estimated annual burden requested is
1,273 hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Interested community members .....................
Eligible study respondents ..............................
Eligible study respondents ..............................
Eligible respondents ........................................
Eligible respondents ........................................
Screening/Baseline Survey ............................
Symptom Survey ............................................
Record of Time Spent Outdoors ....................
Provide Blood Specimen ................................
Provide Specimens (urine, nasal swabs, lung
function test).
Be Outfitted with Personal Air sampler ..........
Provide Fish (if respondent went fishing and
caught fish).
Eligible respondents ........................................
Eligible respondents ........................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–03343 Filed 2–19–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–20–0997]
Agency Forms Undergoing Paperwork
Reduction Act Review
lotter on DSKBCFDHB2PROD with NOTICES
Number of
respondents
Type of respondents
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Standardized
National Hypothesis Generating
Questionnaire to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on October
VerDate Sep<11>2014
19:48 Feb 19, 2020
Jkt 250001
18, 2019 to obtain comments from the
public and affected agencies. CDC
received one non-substantive public
comment related to the previous notice.
This notice serves to allow an additional
30 days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
(in hours)
84
67
67
67
67
1
10
5
3
10
15/60
15/60
10/60
15/60
1
67
67
5
5
45/60
10/60
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Proposed Project
Standard National Hypothesis
Generating Questionnaire (OMB Control
No. 0920–0997, Exp. 02/29/2020)—
Revision—National Center for Emerging
and Zoonotic Infectious Diseases
E:\FR\FM\20FEN1.SGM
20FEN1
]]>Agencies
[Federal Register Volume 85, Number 34 (Thursday, February 20, 2020)]
[Notices]
[Pages 9777-9778]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-03343]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-20-19BPL]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled Aerosols from cyanobacterial blooms:
Exposures and health effects in a highly exposed population, to the
Office of Management and Budget (OMB) for review and approval. CDC
previously published a ``Proposed Data Collection Submitted for Public
Comment and Recommendations'' notice on September 19, 2019 to obtain
comments from the public and affected agencies. CDC received 162
comments related to the previous notice. This notice serves to allow an
additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to [email protected]. Direct written comments
and/or suggestions regarding the items contained in this notice to the
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide
written comments within 30 days of notice publication.
Proposed Project
Aerosols from cyanobacterial blooms: Exposures and health effects
in a highly exposed population--New--National Center for Environmental
Health (NCEH), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Algal toxins from cyanobacterial harmful algal blooms (CyanoHABs)
include some of the most potent natural chemicals. People and animals
are at risk for exposure to toxins produced by CyanoHABs in
recreational waters, drinking water sources, or in improperly treated
water used for medical purposes such as renal dialysis. Additional
potential exposure sources include contaminated dietary supplements or
fish harvested from lakes with ongoing CyanoHABs.
Although outbreaks of human illness associated with CyanoHABs were
sporadically recorded for decades, information about clinical signs and
symptoms from cyanobacterial toxin poisonings is primarily from animal
poisonings and laboratory studies. The primary effects include acute
hepatotoxicity, acute neurotoxicity, gastrointestinal symptoms, and
respiratory, dermatologic, and allergic reactions.
A significant source of cyanobacterial toxin exposure is
recreational use of contaminated fresh water bodies because large
populations are likely to be exposed and toxins may occur in high
concentrations. In the United States, the U.S. Environmental
[[Page 9778]]
Protection Agency (EPA) provided guidance, but not regulations, on
acceptable levels of the cyanobacterial toxins, microcystins and
cylindrospermopsin, in drinking and recreational waters. Data from
epidemiologic studies designed to evaluate the associations among
environmental cyanobacteria toxin concentrations, human biomarkers of
cyanobacteria toxin exposure, and health symptoms are needed to develop
more specific exposure guidelines.
In addition to cyanobacterial toxins, other chemicals produced by
cyanobacteria, such as geosmin and methylisoborneal (MIB), may be
present in aerosols generated during a CyanoHAB. Geosmin and MIB
produce a musty odor and taste in water that is noticeable at very low
concentrations. CyanoHABs may present additional health risks as they
die off and release hydrogen sulfide and methane into the air.
The National Center for Environmental Health (NCEH), Centers for
Disease Control and Prevention (CDC), requests a three-year Paperwork
Reduction Act (PRA) clearance for a new information collection request
titled ``Aerosols from cyanobacterial blooms: exposures and health
effects.'' NCEH is authorized to conduct research under the Public
Health Service Act, Section 301, ``Research and investigation,'' (42
U.S.C. 241). We will conduct a cohort study of 200 people highly
exposed to CyanoHABs in Florida. We define ``highly exposed'' as those
exposed because of their occupation (e.g., lock gate keepers, fishing
guides) and those exposed because they live on a canal or river and
spend at least two hours outside on most days.
Bloom composition and concentrations of toxins can vary over time
during a bloom and CDC is interested in not only exposure, but also how
exposure varies as the blooms develop, mature, and die off. We cannot
predict when or where a bloom may occur. Thus, we will work closely
with the Florida Department of Environmental Protection to identify
when a bloom develops. Once a bloom is verified, we will initiate the
study (i.e., recruit and enroll participants) in the area affected by
the bloom. We will collect data on five study days for each participant
during the bloom season (approximately March-November). The estimated
annual burden requested is 1,273 hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Interested community members.......... Screening/Baseline 84 1 15/60
Survey.
Eligible study respondents............ Symptom Survey.......... 67 10 15/60
Eligible study respondents............ Record of Time Spent 67 5 10/60
Outdoors.
Eligible respondents.................. Provide Blood Specimen.. 67 3 15/60
Eligible respondents.................. Provide Specimens 67 10 1
(urine, nasal swabs,
lung function test).
Eligible respondents.................. Be Outfitted with 67 5 45/60
Personal Air sampler.
Eligible respondents.................. Provide Fish (if 67 5 10/60
respondent went fishing
and caught fish).
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2020-03343 Filed 2-19-20; 8:45 am]
BILLING CODE 4163-18-P
